Senator Investment Group LP Neurocrine Biosciences Inc Transaction History

Senator Investment Group LP

  • $2.03 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$89.43 - $102.27 $13.9 Million - $15.9 Million
-155,000 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$87.57 - $119.4 $13.6 Million - $18.5 Million
155,000 New
155,000 $15.1 Million
Q1 2019

May 15, 2019
SELL
$69.31 - $91.53 $20.8 Million - $27.5 Million
-300,000 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$68.32 - $124.36 $20.5 Million - $37.3 Million
300,000 New
300,000 $21.4 Million

Others Institutions Holding NBIX

# of Institutions
616
Shares Held
94.2M
Call Options Held
557K
Put Options Held
545K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.8B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Senator Investment Group LP Portfolio

Follow Senator Investment Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Senator Investment Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Senator Investment Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email